Inclusion Criteria

Inclusion criteria include:

- Histologically confirmed non-small cell bronchogenic carcinoma, including squamous
cell carcinoma, undifferentiated carcinoma, adenocarcinoma, mixed (adenocarcinoma
with squamous cell carcinoma), bronchoalveolar carcinoma, or large cell carcinoma

- Stage IV or Stage IIIB

- Progressed during or after first-line therapies with platinum-containing regimens in
the advanced or metastatic treatment regimen

- At least 18 years of age

- Good performance status (ECOG 0 to 1)

- Adequate liver, renal, and bone marrow function

Exclusion criteria include:

- Pregnant or lactating women

- Treatment with more than one cytotoxic therapy

- Prior radiation to the whole pelvis

- Unstable medical conditions such as uncontrolled cardiac arrhythmia

- Patients with known history of severe hypersensitivity reactions to docetaxel or
other drugs formulated with polysorbate 80